tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Advertisement

ARS Pharmaceuticals (SPRY) Ownership - Who Owns ARS Pharmaceuticals?

Compare
420 Followers

ARS Pharmaceuticals (SPRY) Ownership Overview

69.65%10.15%0.16%8.55%11.49%
69.65% Insiders
0.16% Other Institutional Investors
8.55% ETFs
11.49% Public Companies and
Individual Investors
The ownership structure of ARS Pharmaceuticals (SPRY) stock is a mix of institutional, retail, and individual investors. Approximately 18.86% of the company’s stock is owned by Institutional Investors, 69.65% is owned by Insiders, and 11.49% is owned by Public Companies and Individual Investors.
The ownership structure of ARS Pharmaceuticals (SPRY) stock is a mix of institutional, retail, and individual investors. Approximately 10.31% of the company’s stock is owned by Institutional Investors, 69.65% is owned by Insiders, and 8.55% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 01, 2025
xxxxxxxxxxxxx
$13663151
May 22, 2025
xxxxxxxxxxxxx
$1450833
May 22, 2025
xxxxxxxxxxxxx
$1710000
May 22, 2025
xxxxxxxxxxxxx
$705000

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,403,141Insider11.61%200,239,156
11,403,141Insider11.61%200,239,156
10,860,977Institution11.06%190,718,756
10,860,977Insider11.06%190,718,756
10,514,657Institution10.71%184,637,377
9,774,508Insider9.95%171,640,360
8,288,510Insider8.44%145,546,236
8,288,510Insider8.44%145,546,236
4,824,554Insider4.91%84,719,168
3,479,064Institution3.54%61,092,364

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,906,154Institution2.96%51,032,064
1,136,838Institution1.16%19,962,875
1,012,056Institution1.03%17,771,703
795,845Institution0.81%13,975,038
654,375Institution0.67%11,490,825
544,586Institution0.55%9,562,930
539,702Institution0.55%9,477,167
364,054Institution0.37%6,392,788
272,543Institution0.28%4,785,855
271,246Institution0.28%4,763,080

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,178,862Institution2.22%31,440,979
1,384,069Institution1.41%24,304,252
1,009,682Institution1.03%17,861,275
815,957Institution0.83%11,774,260
482,717Institution0.49%8,476,511
329,995Institution0.34%5,794,712
249,446Institution0.25%3,599,506
249,223Institution0.25%4,408,755
169,523Institution0.17%2,976,824
146,982Institution0.15%2,581,004

FAQ

Who Owns ARS Pharmaceuticals (SPRY)?
According to the latest TipRanks data, approximately 0.16% of the company's stock is held by institutional investors, 69.65% is held by insiders, and 11.49% is held by retail investors.
    What percentage of ARS Pharmaceuticals (SPRY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.16% of ARS Pharmaceuticals (SPRY) stock is held by institutional investors.
      What percentage of ARS Pharmaceuticals (SPRY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 11.49% of ARS Pharmaceuticals (SPRY) stock is held by retail investors.
        Who owns the most shares of ARS Pharmaceuticals (SPRY)?
        Richard Lowenthal owns the most shares of ARS Pharmaceuticals (SPRY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis